Does high polyunsaturated free fatty acid level at the feto-maternal interface alter steroid hormone message during pregnancy?

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 60, Issue 5-6, 1999, Pages 393-399

  Benassayag, C ^a   Rigourd, V ^a   Mignot, T M ^a   Hassid, J ^b   Leroy, M J ^a   Robert, B ^a   Civel, C ^a   Grange G ^a   Dallot, E ^a   Tanguy, J ^a   Nunez, E A ^b   Ferre F ^a  

^a Univ René Descartes ^*  (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; GESTAGEN; POLYUNSATURATED FATTY ACID; PROGESTERONE RECEPTOR; STEROID HORMONE;

BLOOD PLACENTA BARRIER; CONFERENCE PAPER; FEMALE; FETUS; HUMAN; HUMAN TISSUE; MATERNAL BLOOD; MYOMETRIUM; NORMAL HUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; UMBILICAL CORD BLOOD;

EID: 0032802904     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(99)80019-2     Document Type: Conference Paper

References (32)

1. 1. Coleman R. A. The role of the placenta in lipid metabolism and transport. Semin Perinatol 1989; 13: 180-191.
2. 2. Crawford M. A., Doyle W., Williams G., Drury P. J. The role of fats and EFAs for energy and cell structures in the growth of fetus and neonate. In: The Role of Fats in the Human Nutrition. Vergroesen A. J., Crawford M. A. (Eds). New York: Academic Press 1989; 81-115.
3. 3. Kaufman P., Burton G. Anatomy and genesis of the placenta. In: The Physiology of Reproduction. Knobil E. K., Neill J. D. (Eds). New York: Raven Press Ltd, 1994; 441-484.
4. 4. Yaqoob P., Calder P. C. The effects of fatty acids on lymphocyte functions. Int J Biochem 1993; 25: 1705-1714.
5. 5. Khair-El-Din T. A., Sicher S. C., Vazquez M. C., Wright W. J., Lu C. Docoshexaenoic acid, a major constituent of fetal serum and fish oil diets, inhibits INFY-induced Ia-expression by murine macrophage in vitro. J Immunol 1995; 154: 1296-1306.
6. 6. Lalmanach Girard A. C., Guillaumin M. et al. Inhibition of induced lymphocyte proliferation by lipid and protein components of the syncytiotrophoblast plasma membrane. AJRI 1995; 33: 182-189.
7. 7. Siiteri P. K., Stites D. Immunologic and endocrine interrelationship in pregnancy. Biol Reprod 1982; 26: 1-14.
8. 8. Tessier C., Fayard J. M., Cohen H., Pageaux J. F., Lagarde M., Laugier C. Docosahexaenoic acid is a potent inhibitor of rat uterine stromal cell proliferation. Biochem Biophys Res Commun 1995; 207: 1015-1021.
9. 9. Graber R., Sumida C., Nunez E. A. Fatty acids and cell signal transduction. J Lipid Mediators Cell Signalling 1994; 9: 91-116.
10. 10. Nunez E. A., Haourigui M., Martin M. E., Benassayag C. Fatty acids and steroids hormone action. Prostaglandins Leukot Essent Fatty Acids 1995; 52: 185-190.
11. 11. Martin M. E., Benassayag C., Nunez E. A. Selective changes in binding and immunological properties of human corticosteroid binding globulin by free fatty acids. Endocrinology 1988; 123: 1178-1186.
12. 12. Haourigui M., Sakr S., Martin M. E. et al. Postprandial free fatty acids stimulate activity of human corticosteroid binding globulin. Am J Physiol 1995; 269, 32: 1067-1075.
13. 13. Haourigui M., Thobie N., Martin M. E., Benassayag C., Nunez E. A. In vivo transient rise in plasma free fatty acids alters the functional properties of alpha-fetoprotein. Biochim Biophys Acta 1992; 1125: 157-165.
14. 14. Haourigui M., Vallette G., Martin M. E., Sumida C., Benassayag C., Nunez E. A. In vivo effect of free fatty acids on the specific binding of glucocorticosteroids to Corticosteroid binding globulin and liver receptors in immature rats. Steroids 1994; 59: 46-54.
15. 15. Benassayag C., Vallette G., Hassid J., Raymond J. P., Nunez E. A. Potentiation of estradiol binding to human tissue proteins by unsaturated nonesterified fatty acids. Endocrinology 1986; 118: 1-7.
16. 16. Vallette G., Christeff N., Bogard C., Benassayag C., Nunez E. A. Dynamic pattern of estradiol binding to uterine receptors of the rat. J Biol Chem 1988; 263: 3639-3645.
17. 17. Kato J. Arachidonic acid as a possible modulator of estrogen, progestin, androgen and glucocorticoid receptors in the central and peripheral tissues. J Steroid Biochem 1989; 34: 219-227.
18. 18. Vallette G., Vannet A., Sumida C., Nunez E. A. Modulatory effects of unsaturated fatty acids on the binding of glucocorticoids to liver glucocorticoid receptors. Endocrinology 1991; 129: 1363-1369.
19. 19. Benassayag C., Vitte C., Hassid J. et al. Phytoestrogens and free fatty acids nutrional factors, as modulators of the estrogen action in target cells. Proceedings of the XVI International cancer congress. (Eds) Monduzzi. New Delhi 1994; 1: 609-613.
20. 20. Benassayag C., Mignot T. M., Haourigui M. et al. High polyunsaturated fatty acid, thromboxane A2 and alphafetoprotein concentrations at the human feto-maternal interface. J Lipid Res 1997; 38: 71-81.
21. 21. Laurell C. B. Electroimmunoassay. Scand J Clin Lab Invest 1972; 29: 21-23.
22. 22. Vallette G., Vranckx R., Martin M. E., Benassayag C., Nunez E. A. Conformational changes in rodent and human alpha-fetoprotein: influence of fatty acids. Biochim Biophys Acta 1989; 997: 302-312.
23. 23. Magne D., Seta N., Lebrun D., Durand G., Durand D. Factors influencing the reaction of alpha-fetoprotein with Concanavalin A and Lens culinaris Agglutin in crossed affino-immunoelectrophoresis. Clin Chem 1992; 38: 1418-1424.
24. 24. Cavaillé F., Fournier T., Dallot E., Dhellemes C., Ferré F. Myosin heavy chain isoform expression in human myometrium: presence of an embryonic nonmuscle isoform in leiomyomas and in cultured cells. Cell Mol Cytoskel 1995; 30: 183-193.
25. 25. Clark J. H., Mani S. K. Actions of ovarian steroid htormones. In: Knobil E., Neill J. D., Ewing L. L., Greenwald G. S., Marke C. L., Pfaff D. W. (Eds). The physiology of Reproduction. New York: Raven Press, 1994; 1011-1059.
26. 26. Ferré F., Janssens Y., Tangy G., Breuiller M., De Pariente D., Cedard L. Steroid concentration in human myometrial and placental tissues at the 39th week of pregnancy. Am J Obstet Gynecol 1978; 131: 500-502.
27. 27. Doualla-Bell Kotto Maka F., Ferré F. Regulation of myometrial contractility in human pregnancy. In: Care, Concern and Cure in perinatal medicine. Koppe J. G., Eskes T. K. A. B., Van Geijn H. P., Wiesenhaan P. S., Ruys J. H. (Eds). New York: The Partenon, 1992; 131-146.
28. 28. Padayachi T., Pegooraro R. J., Rom L., Joubert S. M. Enzyme immunoassay of estrogen and progesterone receptors in uterine and intrauterine tissue during human pregnancy and labour. J Steroid Biochem Mol Biol 1990; 37: 509-511.
29. 29. Perrot-Applanat M., Deng M., Fernandez H., Lelaidier C., Meduri G., Bouchard P. Immunohistochemical localization of estradiol and progesterone receptors in human uterus throughout pregnancy: expression in endometrial blood vessels. J Clin Endocrinol Metab 1994; 78: 216-224.
30. 30. How H., Huang Z. H., Zuo J., Lei Z. M., Spinnato J. A., Rao Ch. V. Myometrial estradiol and progesterone receptor changes in preterm and term pregnancies. Obstet Gynecol 1995; 86: 936-940.
31. 31. Toder V., Blank M., Gold-Gefter L., Nebel L. The effect of alpha-fetoprotein on the growth of placental cells in vitro. Placenta 1983; 4: 79-86.
32. 32. Yamashita T., Nakane A., Watanabe T., Miyoshi I., Kasai N. Evidence that alpha-fetoprotein suppresses the immunological function in transgenic mice. Biochem Biophys Res Commun 1994; 201: 1154-1159.